Startseite Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
Artikel Open Access

Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3

  • Jie Wang , Li-Sha Luo , Yu-Cong Deng , Zhong-Chao Li EMAIL logo und Da-Yong Peng ORCID logo EMAIL logo
Veröffentlicht/Copyright: 3. März 2022
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 237 Heft 3

Abstract

C15H15N1O3, triclinic, P 1 ‾ (no. 2), a = 7.1053(11) Å, b = 8.3014(12) Å, c = 11.0297(16) Å, α = 85.810(2)°, β = 79.896(2)°, γ = 87.055(2)°, V = 638.28(16) Å3, Z = 2, R gt (F) = 0.0371, wR ref (F 2) = 0.1062, T = 296(2) K.

CCDC no.: 2153603

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless block
Size: 0.16 × 0.16 × 0.12 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.09 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 25.5°, 99%
N(hkl)measured, N(hkl)unique, R int: 4943, 2357, 0.019
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2003
N(param)refined: 174
Programs: Bruker [1], SHELX [2, 3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.25591 (18) 0.49996 (16) 0.42669 (13) 0.0406 (3)
C2 0.2102 (2) 0.64990 (18) 0.47322 (15) 0.0505 (4)
H2 0.1932 0.7405 0.4209 0.061*
C3 0.1905 (2) 0.66205 (19) 0.59861 (15) 0.0537 (4)
H3 0.1613 0.7628 0.6303 0.064*
C4 0.21277 (19) 0.5279 (2) 0.68005 (14) 0.0496 (4)
C5 0.26202 (19) 0.38007 (19) 0.63054 (13) 0.0451 (3)
H5 0.2803 0.2897 0.6828 0.054*
C6 0.28481 (18) 0.36396 (16) 0.50350 (12) 0.0393 (3)
C7 0.34343 (19) 0.21508 (16) 0.44652 (12) 0.0407 (3)
H7 0.3682 0.1232 0.4956 0.049*
C8 0.36317 (18) 0.20602 (16) 0.32403 (12) 0.0389 (3)
C9 0.32487 (19) 0.34800 (16) 0.24441 (13) 0.0428 (3)
C10 0.44890 (19) 0.05567 (16) 0.26349 (12) 0.0396 (3)
C11 0.1470 (2) 0.0181 (2) 0.18220 (17) 0.0617 (5)
H11A 0.1375 0.1069 0.1211 0.074*
H11B 0.0694 0.0450 0.2601 0.074*
C12 0.0876 (3) −0.1380 (2) 0.14008 (16) 0.0636 (5)
H12A 0.0443 −0.2129 0.2099 0.076*
H12B −0.0138 −0.1183 0.0916 0.076*
C13 0.2681 (3) −0.2022 (2) 0.06258 (15) 0.0593 (4)
H13A 0.2867 −0.1495 −0.0198 0.071*
H13B 0.2642 −0.3179 0.0565 0.071*
C14 0.4249 (2) −0.16274 (17) 0.13075 (13) 0.0482 (4)
H14A 0.4505 −0.2514 0.1886 0.058*
H14B 0.5420 −0.1393 0.0738 0.058*
C15 0.1845 (3) 0.5447 (3) 0.81726 (16) 0.0681 (5)
H15A 0.0526 0.5299 0.8525 0.102*
H15B 0.2196 0.6504 0.8327 0.102*
H15C 0.2631 0.4644 0.8539 0.102*
N1 0.34679 (16) −0.01884 (14) 0.19575 (11) 0.0456 (3)
O1 0.27427 (14) 0.49030 (11) 0.30093 (9) 0.0456 (3)
O2 0.33608 (18) 0.35333 (13) 0.13411 (9) 0.0594 (3)
O3 0.60951 (15) 0.00625 (13) 0.27901 (10) 0.0578 (3)

Source of material

To a stirred solution of 6-methyl-2-oxo-2H-chromene-3-carboxylic acid (0.612 g, 3 mmol), N,N-Dimethylformamide (DMF) (0.007 g, 0.1 mmol) was added dropwise SOCl2 (2.975 g, 25 mmol) at 0 ∘C for 30 min, then enhanced to 95 ∘C for 4 h. The reaction was monitored by thin-layer chromatography (TLC). Next, unreacted SOCl2 was removed. Then 15 mL of anhydrous CH2Cl2 was added. Pyrrolidine (0.22 g, 3.1 mmol) and TEA (0.607 g, 6 mmol) were dissolved in 10 mL of anhydrous CH2Cl2. This solution was added dropwise to the reaction mixture at room temperature. The reaction was monitored by TLC. After, CH2Cl2 was removed. At last, the reaction mixture was allowed to recrystallize from methanol to obtain 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one.

Experimental details

All H atoms were included in calculated positions and refined as riding atoms, with C–H = 0.90–0.97 Å with U iso(H) = 1.5 U eq(C) for methyl H atoms and 1.2 U eq(C) for all other H atoms.

Comment

Coumarin and its derivatives are heterocyclic compounds with a benzopyrone structure [5, 6], which may have excellent antiviral [7], antioxidation [8] antibacterial [9, 10], anticancer [11] and many other physiological, pharmacological activities and optical properties [12]. Among them, coumarin-3-carboxylic acids are vital precursors for the synthesis of active compounds such as dicoumarol, fluorocoumarin carboxylate and coumarin amide [13, 14]. Therefore, it is a research hotspot to explore the efficient synthesis of coumarin-3-carboxylic acids [15], [16], [17].

In the molecule of the title compound (fig.), bond lengths and angles are very similar to those given in the literature for coumarin derivatives [15–18]. In the molecules of the title structure, the coumarin moiety is approximately planar. The dihedral angle between the coumarin moiety and the plane of amides part (C10–N1–O3) is 62.8°. The pyrrolidine part adopts an envelope conformation. The torsion angles of C8–C10–N1–C11, C10–N1–C11–C12, N1–C11–C12–C13, C11–C12–C13–C14 and C12–C13–C14–N1 are −7.0(2)°, −158.5(1)°, −33.7(2)°, 38.6(2)° and −27.7(2)°, respectively.

Corresponding authors: Zhong-Chao Li, Saerfu(Henan) Agrochemical Co., Ltd, Mengzhou 454750, People’s Republic of China, E-mail: ; and Da-Yong Peng, Key Laboratory of Chemical Utilization of Plant Resources of Nanchang, College of Chemistry and Materials, Jiangxi Agricultural University, Nanchang 330045, People’s Republic of China, E-mail:

Funding source: National Key Research Program of China

Award Identifier / Grant number: 2017YFD0301604

Funding source: National Natural Science Foundation of China http://dx.doi.org/10.13039/501100001809

Award Identifier / Grant number: 32160660

Award Identifier / Grant number: 21562022

Funding source: Natural Science Foundation of Jiangxi Province

Award Identifier / Grant number: 20181BAB203015

Acknowledgments

X-ray data were collected at Instrumental Analysis Center Nanchang Hangkong University, Nanchang, 330063, People’s Republic of China.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the “13th Five-Year” National Key Research Program of China (2017YFD0301604), the National Natural Science Foundation of China (32160660, 21562022), the Natural Science Foundation of Jiangxi Province (Grant No. 20181BAB203015).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. Apex2, Saint and Sadabs; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Brandenburg, K. Diamond. Visual Crystal Structure Information System (ver. 4.0); Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

5. Li, M. Y., Li, F. H., Lan, M. X., Li, Q., Ren, M. R., Wu, G. X. A study on the antioxidant active components of Trigonostemon howii. Acta Agric. Univ. Jiangxiensis 2021, 43, 305–312; https://doi.org/10.13836/j.jjau.2021035.Suche in Google Scholar

6. Tang, W. W., Liu, X. L., Zeng, D. Q. Natural products with bioactivity against Plutella xylostella L. isolated from Solanum torvum swartz. Acta Agric. Univ. Jiangxiensis 2012, 34, 483–486; https://doi.org/10.13836/j.jjau.2012090.Suche in Google Scholar

7. Liu, L., Song, D. W., Liu, G. L., Shan, L. P., Qiu, T. X., Chen, J. Hydroxycoumarin efficiently inhibits spring viraemia of carp virus infection in vitro and in vivo. Zool. Res. 2020, 41, 395–409; https://doi.org/10.24272/j.issn.2095-8137.2020.037.Suche in Google Scholar

8. Nicolaides, D. N., Gautam, D. R., Litinas, K. E., Hadjipavlou-Litina, D. J., Fylaktakidou, K. C. Synthesis and evaluation of the antioxidant and antiinflammatory activities of some benzo[l]khellactone derivatives and analogues. Eur. J. Med. Chem. 2004, 39, 323–332; https://doi.org/10.1016/j.ejmech.2004.01.003.Suche in Google Scholar

9. Wang, Y. H., Jiang, S. C., Chen, Y., Guo, T., Xia, R. J., Tang, X., He, M., Xue, W. Synthesis and antibacterial activity of novel chalcone derivatives bearing a coumarin moiety. Chem. Pap. 2019, 73, 2493–2500; https://doi.org/10.1007/s11696-019-00802-0.Suche in Google Scholar

10. Jardosh, H. H., Patel, M. P. Microwave-assisted CAN-catalyzed solvent-free synthesis of N-allyl quinolone-based pyrano [4, 3-b] chromene and benzopyrano [3, 2-c] chromene derivatives and their antimicrobial activity. Med. Chem. Res. 2013, 22, 905–915; https://doi.org/10.1007/s00044-012-0085-z.Suche in Google Scholar

11. Goud, N. S., Pooladanda, V., Mahammad, G. S., Jakkula, P., Gatreddi, S., Qureshi, I. A., Chandraiah Godugu, R. A., Alvala, M. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents. Chem. Biol. Drug. Des. 2019, 94, 1919–1929; https://doi.org/10.1111/cbdd.13578.Suche in Google Scholar

12. Ren, X., Kondakova, M. E., Giesen, D. J., Rajeswaran, M., Madaras, M., Lenhart, W. C. Coumarin-based, electron-trapping iridium complexes as highly efficient and stable phosphorescent emitters for organic light-emitting diodes. Inorg. Chem. 2010, 49, 1301–1303; https://doi.org/10.1021/ic9022097.Suche in Google Scholar

13. Bakare, S. B. Synthesis and anticancer evaluation of some coumarin and azacoumarin derivatives. Pol. J. Chem. Technol. 2021, 23, 27–34; https://doi.org/10.2478/pjct-2021-0013.Suche in Google Scholar

14. Vega-Granados, K., Medina-O’Donnell, M., Rivas, F., Reyes-Zurita, F. J., Martinez, A., Alvarez de Cienfuegos, L., Lupianez, J. A., Parra, A. Synthesis and biological activity of triterpene coumarin conjugates. J. Nat. Prod. 2021, 84, 1587–1597; https://doi.org/10.1021/acs.jnatprod.1c00128.Suche in Google Scholar

15. Mzozoyana, V., Zamisa, S. J. Crystal structure of 4-(3-fluorophenyl)-7-hydroxy-2H-chromen-2-one, C15H9FO3. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 631–633.10.1515/ncrs-2019-0869Suche in Google Scholar

16. Yu, X., Chen, Y. F., Huang, G. J., Zhang, Y. F., Yang, W. D. Synthesis and crystal structure of 4-(3-acetyl-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-7-(diethylamino)-2H-chromen-2-one, C21H21N3O4S. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 561–562.10.1515/ncrs-2019-0807Suche in Google Scholar

17. Mzozoyana, V., Zamisa, S. J. Crystal structure of 7-hydroxy-4-phenyl-2H-chromen-2-one, C15H10O3. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 595–597.10.1515/ncrs-2019-0839Suche in Google Scholar

18. Zeng, F. X., Nie, X. L., Shang-guan, X. C., Yin, Z. P., Peng, D. Y. Crystal structure of 3-methyl-2H-chromen-2-one, C10H8O2. Z. Kristallogr. N. Cryst. Struct. 2016, 231, 975–976.10.1515/ncrs-2016-0028Suche in Google Scholar
Received: 2022-01-12
Accepted: 2022-02-21
Published Online: 2022-03-03
Published in Print: 2022-06-27

© 2022 Jie Wang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
https://doi.org/10.1515/ncrs-2022-0011
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 10.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0011/html?lang=de
Button zum nach oben scrollen